U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

Results: 1 to 20 of 190

Tests names and labsConditionsGenes, analytes, and microbesMethods

MVL Vision Panel

Molecular Vision Laboratory
United States
13581028
  • C Sequence analysis of the entire coding region

MET - NGS including CNV analysis

Centogene US, LLC - The Rare Disease Company
United States
51
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoIEM Panel

Centogene US, LLC - The Rare Disease Company
United States
669688
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoImmuno Panel

Centogene US, LLC - The Rare Disease Company
United States
323329
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoVision Panel

Centogene US, LLC - The Rare Disease Company
United States
417413
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Pancreatitis Panel

Centogene US, LLC - The Rare Disease Company
United States
2729
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoNeuro Panel

Centogene US, LLC - The Rare Disease Company
United States
18861858
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Intellectual Disability Panel

Centogene US, LLC - The Rare Disease Company
United States
777770
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

APC - NGS including CNV analysis

Centogene US, LLC - The Rare Disease Company
United States
51
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CASP8 - NGS including CNV analysis

Centogene US, LLC - The Rare Disease Company
United States
41
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

APC - MLPA

Centogene US, LLC - The Rare Disease Company
United States
51
  • D Deletion/duplication analysis

TP53 - MLPA

Centogene US, LLC - The Rare Disease Company
United States
121
  • D Deletion/duplication analysis

CTNNB1 - NGS including CNV analysis

Centogene US, LLC - The Rare Disease Company
United States
61
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Solid Tumor Panel

Centogene US, LLC - The Rare Disease Company
United States
218135
  • C Sequence analysis of the entire coding region

Myeloid Tumor Panel

Centogene US, LLC - The Rare Disease Company
United States
7434
  • C Sequence analysis of the entire coding region

PIK3CA - NGS including CNV analysis

Centogene US, LLC - The Rare Disease Company
United States
141
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

TP53 - NGS including CNV analysis

Centogene US, LLC - The Rare Disease Company
United States
121
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Solid Tumor Panel

Centogene AG - the Rare Disease Company
Germany
218135
  • C Sequence analysis of the entire coding region

Myeloid Tumor Panel

Centogene AG - the Rare Disease Company
Germany
7434
  • C Sequence analysis of the entire coding region

CTNNB1 - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
61
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 190

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.